Loading

Where Have All the T Cells Gone?

August 14, 2018 New research proposes a novel mechanism for how tumors sidestep the immune system in patients with intracranial tumors.   Although T-cell lymphopenia in glioblastoma (GBM) is often attributed to the medications administered…

Loading

Crizotinib as the Standard of Care in Advanced…

November 21, 2018 Responses to crizotinib in ALK+ inflammatory myofibroblastic tumors were consistent with responses in ALK+ NSCLC, according to presenter Dr Schöffski. Patrick Schöffski, MD, of the Katholieke Universiteit Leuven in Belgium, presented data…

2018 World Conference on Lung Cancer: 8 Key…

November 21, 2018 In a phase 3 trial, durvalumab was found to prolong survival in patients with stage III NSCLC. Lung Cancer Awareness Month is an opportunity to focus on promising research in the field.…